0 Комментарии
0 Поделились
314 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Marketplace
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Комментарии 0 Поделились 400 Просмотры 0 предпросмотр
-
Is the Global Inhaled Antibiotics Market Advancing Respiratory Infection Management?Detailed Analysis of Executive Summary Inhaled Antibiotics Market Size and Share Data Bridge Market Research analyses that the Inhaled Antibiotics market which was USD 1,274.12 million in 2022, would rocket up to USD 2,046.13 million by 2030, and is expected to undergo a CAGR of 6.1% during the forecast period The Inhaled Antibiotics report makes available the current and forthcoming...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Is the Global Malaria Treatment Market Advancing with Novel Antimalarial Therapies?Future of Executive Summary Malaria Treatment Market: Size and Share Dynamics The expected CAGR of malaria treatment market is tend to be around 6.6% in the mentioned forecast period. The market value is USD 647.13 million in 2022, and it would grow upto USD 1079.07 million by 2030. This Malaria Treatment Market research report serves the determination of businesses to make enhanced...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Will Endocrine Resistance-Targeting Drugs Transform the Future of Cancer Therapy?Market Trends Shaping Executive Summary Endocrine Resistance–Targeting Drug Market Market Size and Share CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...0 Комментарии 0 Поделились 807 Просмотры 0 предпросмотр
Спонсоры
Спонсоры